Mesoblast Limited vs Under Armour Inc Class A — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Under Armour Inc Class A trades at $5.4 (market cap $2.26B). The key difference: Mesoblast Limited and Under Armour Inc Class A are close in size by market cap, and Mesoblast Limited is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals.
| MESO | UAA | |
|---|---|---|
Market Cap | $2.21B | $2.26B |
Sector | Technology | Consumer Cyclical |
52-Week High | $20.96 | $8.14 |
52-Week Low | $12.88 | $4.17 |
Enterprise Value | $2.21B | $3.24B |
Trailing returns across standard periods
Latest headlines on both assets
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.
Read more on UAA →